ADAM28: A potential oncogene involved in asbestos-related lung adenocarcinomas

Genes Chromosomes and Cancer

Volumn 49, Issue 8, 2010, Pages 688-698

  Wright, Casey M ^a,b   Larsen, Jill E ^a,b   Hayward, Nicholas K ^c   Martins, Maria U ^b   Tan, Maxine E ^b   Davidson, Morgan R ^a,b   Savarimuthu, Santiyagu M ^a,b   McLachlan, Rebecca E ^b   Passmore, Linda H ^b   Windsor, Morgan N ^b   Clarke, Belinda E ^b   Duhig, Edwina E ^b   Yang, Ian A ^a,b   Bowman, Rayleen V ^a,b   Fong, Kwun M ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM28 PROTEIN; ASBESTOS; BIOLOGICAL MARKER; DISINTEGRIN; INTEGRIN; INTERFERON REGULATORY FACTOR 6; METALLOPROTEINASE; PEROXIREDOXIN 1; PHOSPHOPROTEIN PHOSPHATASE 1; RAB PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; LUNG ADENOCARCINOMA; LUNG TUMOR; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADAM PROTEINS; ADENOCARCINOMA; AGED; ASBESTOS; CARCINOGENS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MALE; OCCUPATIONAL EXPOSURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

NICOTIANA TABACUM;

EID: 77953503932     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20779     Document Type: Article

References (57)

1. Bailey CM, Hendrix MJ. 2008. IRF6 in development and disease: A mediator of quiescence and differentiation. Cell Cycle 7:1925-1930.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Stat Soc Ser B 57:289-300.
3. Billings CG, Howard P. 2000. Asbestos exposure, lung cancer and asbestosis. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace/Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo 55:151-156.
4. Bridges LC, Hanson KR, Tani PH, Mather T, Bowditch RD. 2003. Integrin alpha4beta1-dependent adhesion to ADAM 28 (MDC-L) requires an extended surface of the disintegrin domain. Biochemistry 42:3734-3741. (Pubitemid 36402666)
5. Cardinali G, Kovacs D, Maresca V, Flori E, Dell'anna ML, Campopiano A, Casciardi S, Spagnoli G, Torrisi MR, Picardo M. 2006. Differential in vitro cellular response induced by exposure to synthetic vitreous fibers (SVFs) and asbestos crocidolite fibers. Exp Mol Pathol 81:31-41.
6. Chen JJ, Wang SJ, Tsai CA, Lin CJ. 2007. Selection of differentially expressed genes in microarray data analysis. Pharmacogenomics J 7:212-220. (Pubitemid 46785162)
7. Churg A. 1993. Asbestos, asbestosis, and lung cancer. Modern Pathol 6:509-511.
8. de Medeiros F, Hansen L, Mawlad E, Eiberg H, Asklund C, Tommerup N, Jakobsen LP. 2008. A novel mutation in IRF6 resulting in VWS-PPS spectrum disorder with renal aplasia. Am J Med Genet A 146A:1605-1608. (Pubitemid 351792409)
9. Doll R. 1955. Mortality from lung cancer in asbestos workers. Br J Ind Med 12:81-86.
10. Dopp E, Saedler J, Stopper H, Weiss DG, Schiffmann D. 1995. Mitotic disturbances and micronucleus induction in Syrian hamster embryo fibroblast cells caused by asbestos fibers. Environ Health Perspect 103:268-271.
11. Dusinska M, Collins A, Kazimirova A, Barancokova M, Harrington V, Volkovova K, Staruchova M, Horska A, Wsolova L, Kocan A, Petrik J, Machata M, Ratcliffe B, Kyrtopoulos S. 2004. Genotoxic effects of asbestos in humans. Mutat Res 553:91-102.
12. Dyrskjot L, Thykjaer T, Kruhoffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H, Orntoft TF. 2003. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33:90-96. (Pubitemid 36068689)
13. Egilman D, Reinert A. 1996. Lung cancer and asbestos exposure: Asbestosis is not necessary. Am J Ind Med 30:398-406. (Pubitemid 26337302)
14. Graves JA, Metukuri M, Scott D, Rothermund K, Prochownik EV. 2009. Regulation of reactive oxygen species homeostasis by peroxiredoxins and c-Myc. J Biol Chem 284:6520-6529.
15. Hart S, Fischer OM, Ullrich A. 2004. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res 64:1943-1950. (Pubitemid 38339438)
16. Henderson DW, Rodelsperger K, Woitowitz HJ, Leigh J. 2004. After Helsinki: A multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology 36:517a-550a.
17. Hesterberg TW, Barrett JC. 1985. Induction by asbestos fibers of anaphase abnormalities: Mechanism for aneuploidy induction and possibly carcinogenesis. Carcinogenesis 6:473-475.
18. Hodgson JT, Darnton A. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 44:565-601.
19. Hsu LC, Huang X, Seasholtz S, Potter DM, Gollin SM. 2006. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Oncogene 25:5517-5526. (Pubitemid 44344102)
20. Ishii T, Yamada M, Sato H, Matsue M, Taketani S, Nakayama K, Sugita Y, Bannai S. 1993. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J Biol Chem 268:18633-18666.
21. Kim JH, Bogner PN, Ramnath N, Park Y, Yu J, Park YM. 2007. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin Cancer Res 13:3875-3882.
22. Kim JH, Bogner PN, Baek SH, Ramnath N, Liang P, Kim HR, Andrews C, Park YM. 2008. Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target. Clin Cancer Res 14:2326-2333. (Pubitemid 351551064)
23. Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y. 2002. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 196:316-323. (Pubitemid 34189421)
24. Komuro K, Tada M, Tamoto E, Kawakami A, Matsunaga A, Teramoto K, Shindoh G, Takada M, Murakawa K, Kanai M, et al. 2005. Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res 124:216-224.
25. Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y, Howard E, de Lima RL, Daack-Hirsch S, Sander A, et al. 2002. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 32:285-289.
26. Larsen J, Pavey S, Passmore L, Bowman R, Clarke B, Hayward N, Fong K. 2006. Expression profiling defines a recurrence signature in lung squamous cell carcinoma. Carcinogenesis 27:760-766.
27. Larsen JE, Pavey SJ, Passmore LH, Bowman RV, Hayward NK, Fong KM. 2007. Gene expression signature predicts recurrence in lung adenocarcinoma. Clin Cancer Res 13:2946-2954. (Pubitemid 46849569)
28. Lee BW, Wain JC, Kelsey KT, Wiencke JK, Christiani DC. 1998. Association of cigarette smoking and asbestos exposure with location and histology of lung cancer. Am J Respir Crit Care Med 157:748-755. (Pubitemid 28150683)
29. Lee PN. 2001. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup Environ Med 58:145-153. (Pubitemid 32183408)
30. Libbus BL, Illenye SA, Craighead JE. 1989. Induction of DNA strand breaks in cultured rat embryo cells by crocidolite asbestos as assessed by nick translation. Cancer Res 49:5713-5718.
31. Liddell FD. 2001. The interaction of asbestos and smoking in lung cancer. Ann Occup Hyg 45:341-356. (Pubitemid 32564873)
32. Mitsui Y, Mochizuki S, Kodama T, Shimoda M, Ohtsuka T, Shiomi T, Chijiiwa M, Ikeda T, Kitajima M, Okada Y. 2006. ADAM28 is overexpressed in human breast carcinomas: Implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3. Cancer Res 66:9913-9920. (Pubitemid 44672043)
33. Mochizuki S, Shimoda M, Shiomi T, Fujii Y, Okada Y. 2004. ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin- like growth factor binding protein-3. Biochem Biophys Res Commun 315:79-84. (Pubitemid 38175188)
34. Nymark P, Wikman H, Ruosaari S, Hollmen J, Vanhala E, Karjalainen A, Anttila S, Knuutila S. 2006. Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res 66:5737-5743. (Pubitemid 43927127)
35. Nymark P, Lindholm PM, Korpela MV, Lahti L, Ruosaari S, Kaski S, Hollmen J, Anttila S, Kinnula VL, Knuutila S. 2007. Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines. BMC Genomics 8:62.
36. Nymark P, Wikman H, Hienonen-Kempas T, Anttila S. 2008. Molecular and genetic changes in asbestos-related lung cancer. Cancer Lett 265:1-15.
37. Nymark P, Kettunen E, Aavikko M, Rusosaari S, Kuosma E, Vanhala E, Salmenkivi K, Pirinen R, Karjalainen A, Knuutila S, Wikman H, Anttila S. 2009. Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer. Clinical Cancer Research 15:468-475.
38. Ohtsuka T, Shiomi T, Shimoda M, Kodama T, Amour A, Murphy G, Ohuchi E, Kobayashi K, Okada Y. 2006. ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis. Int J Cancer 118:263-273.
39. Okada Y. 2007. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase). Verh Dtsch Ges Pathol 91:29-38.
40. Okayasu R, Takahashi S, Yamada S, Hei TK, Ullrich RL. 1999. Asbestos and DNA double strand breaks. Cancer Res 59:298-300. (Pubitemid 29048856)
41. Powis G, Montfort W. 2001. Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 41:261-295.
42. Rangasamy T, Cho C, Thimmulappa R, Zhen L, Srisuma S, Kensler T, Yanamoto M, Petrache I, Tuder R, Biswal S. 2004. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114:1248-1259. (Pubitemid 40385296)
43. Raponi M, Zhang Y, Yu J, Chen G, Lee G, Taylor JM, Macdonald J, Thomas D, Moskaluk C, Wang Y, Beer DG. 2006. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 66:7466-7472. (Pubitemid 44289200)
44. Roemer A, Schwettmann L, Jung M, Roigas J, Kristiansen G, Schnorr D, Loening SA, Jung K, Lichtinghagen R. 2004. Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome. Oncol Rep 11:529-536.
45. Ruosaari S, Hienonen-Kempas T, Puustinen A, Sarhadi VK, Hollmen J, Knuutila S, Saharinen J, Wikman H, Anttila S. 2008. Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients. BMC Med Genom 1:55-63.
46. Roggli VL. 1992. Tissue Digestion Techniques in Pathology of Asbestos-Associated Diseases. Boston, Massachusetts: Little Brown and Co. pp. 402-410.
47. Roggli VL, McGavran MH, Subach J, Sybers HD, Greenberg SD. 1982. Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: A study of 25 cases. Cancer 50:2423-32.
48. Ruiz L, Traskine M, Ferrer I, Castro E, Leal JF, Kaufman M, Carnero A. 2008. Characterization of the p53 response to oncogene- induced senescence. PLoS One 3:e3230.
49. Schramm A, Schulte JH, Klein-Hitpass L, Havers W, Sieverts H, Berwanger B, Christiansen H, Warnat P, Brors B, Eils J, et al. 2005. Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling. Oncogene 24:7902-7912.
50. Sehgal A, Keener C, Boynton AL, Young RF, Vermeulen SS, Yonemura KS, Kohler EP, Aldape HC, Simrell CR, Murphy GP. 1997. Isolation and characterization of a novel gene from human glioblastoma multiforme tumor tissue. Int J Cancer 71:565-72. (Pubitemid 27239365)
51. Sun S, Schiller JH, Gazdar AF. 2007. Lung cancer in never smokers- A different disease. Nat Rev Cancer 7:778-790. (Pubitemid 47463669)
52. Topinka J, Loli P, Georgiadis P, Dusinska M, Hurbankova M, Kovacikova Z, Volkovova K, Kazimirova A, Barancokova M, Tatrai E, et al. 2004. Mutagenesis by asbestos in the lung of lambda-lacI transgenic rats. Mutat Res 553:67-78.
53. Vainio H, Boffetta P. 1994. Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health 20:235-242. (Pubitemid 24291305)
54. Wang X, Liu J, Zhang H, Xiao M, Li J, Yang C, Lin X, Wu Z, Hu L, Kong X. 2003. Novel mutations in the IRF6 gene for Van der Woude syndrome. Hum Genet 113:382-386. (Pubitemid 37254242)
55. Wikman H, Ruosaari S, Nymark P, Sarhadi VK, Saharinen J, Vanhala E, Karjalainen A, Hollmen J, Knuutila S, Anttila S. 2007. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer. Oncogene 26:4730-4737. (Pubitemid 47067413)
56. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. 2007. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. BMC Cancer 7:85.
57. Wright CM, Bowman RV, Tan ME, Martins MU, McLachlan RE, Passmore LH, Windsor MN, Clarke BE, Duhig EE, Mahar AM, et al. 2008. Lung asbestos content in lungs resected for primary lung cancer. J Thorac Oncol 3:569-576. (Pubitemid 351787298)